Next Article in Journal
The Grey Zones of Classic Hodgkin Lymphoma
Next Article in Special Issue
Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
Previous Article in Journal
Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis
Previous Article in Special Issue
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
 
 
Review

Article Versions Notes

Cancers 2022, 14(3), 741; https://doi.org/10.3390/cancers14030741
Action Date Notes Link
article pdf uploaded. 31 January 2022 12:12 CET Version of Record https://www.mdpi.com/2072-6694/14/3/741/pdf-vor
article xml file uploaded 8 February 2022 08:59 CET Original file -
article xml uploaded. 8 February 2022 08:59 CET Update https://www.mdpi.com/2072-6694/14/3/741/xml
article pdf uploaded. 8 February 2022 08:59 CET Updated version of record https://www.mdpi.com/2072-6694/14/3/741/pdf
article html file updated 8 February 2022 09:00 CET Original file -
article html file updated 31 July 2022 08:32 CEST Update https://www.mdpi.com/2072-6694/14/3/741/html
Back to TopTop